Skip to main content Skip to footer
Investor Relations
Back to OpusGTX.com
Opus Genetics, Inc. IR Overview
  • Overview
  • Press Releases
  • Events
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed
  • Back to OpusGTX.com

Press Releases

Jul 10, 2023 5:19 pm EDT
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 27, 2023 8:00 am EDT
Ocuphire Presents APX3330 ZETA-1 Clinical Data in Late-Breaker Session at the American Diabetes Association’s Annual Conference
Jun 21, 2023 8:00 am EDT
Ocuphire Announces Late Breaking Presentation on APX3330 ZETA-1 Clinical Data at American Diabetes Association Annual Conference
Jun 12, 2023 8:00 am EDT
Ocuphire Presents APX3330 ZETA-1 Data at Clinical Trials at the Summit (CTS) 2023
May 24, 2023 4:05 pm EDT
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 15, 2023 8:00 am EDT
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
May 2, 2023 8:30 am EDT
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ASCRS 2023 and Eyecelerator
Apr 25, 2023 8:00 am EDT
Ocuphire Provides Corporate Update and Reiterates Previous Guidance on Clinical Programs
Apr 21, 2023 8:00 am EDT
Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer
Mar 30, 2023 8:00 am EDT
Ocuphire Pharma Announces Financial Results for Fourth Quarter and Year Ended 2022 and Provides Corporate Update
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 19
  • Next Pagearrow_forward
rss_feed News RSS
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Opus Genetics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement